Dienogest does not augment the gene expression of adhesion molecules, MCP-1, and monocyte adherence in human endothelial cells

References

• Kannel WB, Hjortland MC, McNamara PM, et al. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85(4):1–6. doi: 10.7326/0003-4819-85-4-447.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316(18):1105–1110. doi: 10.1056/NEJM198704303161801.
   PubMed Web of Science ®Google Scholar
• McGill HC, Jr, Stern MP. Sex and atherosclerosis. Atheroscler Rev. 1979;4:157–242.
   Google Scholar
• Meng Q, Li Y, Ji T, et al. Estrogen prevent atherosclerosis by attenuating endothelial cell pyroptosis via activation of estrogen receptor α-mediated autophagy. J Adv Res. 2021;28:149–164. doi: 10.1016/j.jare.2020.08.010.
   PubMed Web of Science ®Google Scholar
• Lv Y, Zhang S, Weng X, et al. Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2/GPX4 pathway. Faseb J. 2023;37(6):e22992. doi: 10.1096/fj.202300083R.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA. 2002;288(3):321–333. doi: 10.1001/jama.288.3.321.
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health initiative randomized controlled trial. JAMA. 2004;291(14):1701–1712. doi: 10.1001/jama.291.14.1701.
   PubMed Web of Science ®Google Scholar
• Ito F, Tatsumi H, Mori T, et al. Medroxyprogesterone acetate enhances monocyte endothelial interaction under flow conditions by stimulating the expression of cell adhesion molecules. J Clin Endocrinol Metab. 2014;99(6):2188–2197. doi: 10.1210/jc.2013-2925.
   PubMed Web of Science ®Google Scholar
• Ito F, Mori T, Tarumi Y, et al. Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling. PLoS One. 2019;14(1):e0211462. doi: 10.1371/journal.pone.0211462.
   PubMed Web of Science ®Google Scholar
• Løkkegaard E, Andreasen AH, Jacobsen RK, et al. Hormone therapy and risk of myocardial infarction: a national register study. Eur Heart J. 2008;29(21):2660–2668. doi: 10.1093/eurheartj/ehn408.
   PubMed Web of Science ®Google Scholar
• Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103–111. doi: 10.1007/s10549-007-9523-x.
   PubMed Web of Science ®Google Scholar
• Tatsumi H, Kitawaki J, Tanaka K, et al. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas. 2002;42(4):287–294. doi: 10.1016/s0378-5122(02)00157-3.
   PubMed Web of Science ®Google Scholar
• Otsuki M, Saito H, Xu X, et al. Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2001;21(2):243–248. doi: 10.1161/01.atv.21.2.243.
   PubMed Web of Science ®Google Scholar
• Groh LA, Verel DE, van der Heijden CDCC, et al. Immune modulatory effects of progesterone on oxLDL-induced trained immunity in monocytes. J Leukoc Biol. 2022;112(2):279–288. doi: 10.1002/JLB.3AB1220-846R.
   PubMed Web of Science ®Google Scholar
• Banno K, Kisu I, Yanokura M, et al. Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review). Int J Oncol. 2012;40(6):1755–1762. doi: 10.3892/ijo.2012.1384.
   PubMed Web of Science ®Google Scholar
• Grandi G, Mueller M, Bersinger NA, et al. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflamm Res. 2016;65(3):183–192. doi: 10.1007/s00011-015-0909-7.
   PubMed Web of Science ®Google Scholar
• Ichioka M, Mita S, Shimizu Y, et al. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. J Steroid Biochem Mol Biol. 2015;147:103–110. doi: 10.1016/j.jsbmb.2014.12.008.
   PubMed Web of Science ®Google Scholar
• Grandi G, Mueller M, Bersinger N, et al. Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells. Am J Reprod Immunol. 2016;76(4):292–298. doi: 10.1111/aji.12552.
   PubMed Web of Science ®Google Scholar
• Mita S, Shimizu Y, Notsu T, et al. Dienogest inhibits toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells. Fertil Steril. 2011;96(6):1485–1489.e4. doi: 10.1016/j.fertnstert.2011.09.040.
   PubMed Web of Science ®Google Scholar
• Gerszten RE, Luscinskas FW, Ding HT, et al. Adhesion of memory lymphocytes to vascular cell adhesion molecule-1-transduced human vascular endothelial cells under simulated physiological flow conditions in vitro. Circ Res. 1996;79(6):1205–1215. doi: 10.1161/01.res.79.6.1205.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Yoshikawa T, Nakamura Y, et al. Methylprednisolone inhibits neutrophil-endothelial cell interactions induced by interleukin-1β under flow conditions. Life Sci. 1997;60(25):2341–2347. doi: 10.1016/s0024-3205(97)00290-7.
   PubMed Web of Science ®Google Scholar
• Wang YX, Xiang C, Liu B, et al. A multi-component parallel-plate flow chamber system for studying the effect of exercise-induced wall shear stress on endothelial cells. Biomed Eng Online. 2016;15(Suppl 2):154. doi: 10.1186/s12938-016-0273-z.
   PubMedGoogle Scholar
• Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874. doi: 10.1038/nature01323.
   PubMed Web of Science ®Google Scholar
• Burns MP, DePaola N. Flow-conditioned HUVECs support clustered leukocyte adhesion by co-expressing ICAM-1 and E-selectin. Am J Physiol Heart Circ Physiol. 2005;288(1):H194–204. doi: 10.1152/ajpheart.01078.2003.
   PubMed Web of Science ®Google Scholar
• Pateras I, Giaginis C, Tsigris C, et al. NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links. Expert Opin Ther Targets. 2014;18(9):1089–1101. doi: 10.1517/14728222.2014.938051.
   PubMed Web of Science ®Google Scholar
• Xu K, Saaoud F, Yu S, et al. Monocyte adhesion assays for detecting endothelial cell activation in vascular inflammation and atherosclerosis. Methods Mol Biol. 2022;2419:169–182. doi: 10.1007/978-1-0716-1924-7_10.
   PubMedGoogle Scholar
• Luscinskas FW, Gerszten RE, Garcia-Zepeda EA, et al. C-C and C–X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Ann N Y Acad Sci. 2000;902(1):288–293. doi: 10.1111/j.1749-6632.2000.tb06324.x.
   PubMedGoogle Scholar
• Haraldsen G, Kvale D, Lien B, et al. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol. 1996;156(7):2558–2565. doi: 10.4049/jimmunol.156.7.2558.
   PubMed Web of Science ®Google Scholar
• Zielińska KA, Van Moortel L, Opdenakker G, et al. Endothelial response to glucocorticoids in inflammatory diseases. Front Immunol. 2016;7:592. doi: 10.3389/fimmu.2016.00592.
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313–326. doi: 10.1089/jir.2008.0027.
   PubMed Web of Science ®Google Scholar
• Ikeda U. Inflammation and coronary artery disease. Curr Vasc Pharmacol. 2003;1(1):65–70. doi: 10.2174/1570161033386727.
   PubMedGoogle Scholar
• Seino Y, Ikeda U, Takahashi M, et al. Expression of monocyte chemoattractant protein-1 in vascular tissue. Cytokine. 1995;7(6):575–579. doi: 10.1006/cyto.1995.0078.
   PubMed Web of Science ®Google Scholar
• Köhler G, Göretzlehner G, Brachmann K. Lipid metabolism during treatment of endometriosis with the progestin dienogest. Acta Obstet Gynecol Scand. 1989;68(7):633–635. doi: 10.3109/00016348909013283.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gong H, Gou J, et al. Dienogest as a maintenance treatment for endometriosis following surgery: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:652505. doi: 10.3389/fmed.2021.652505.
   PubMed Web of Science ®Google Scholar